2002Chinese Journal of Oral & Maxillofacial SurgeryRequires access

THE DISTRIBUTION AND ARTERY-VEIN-ACCESS OVERFLOW OF ALBUMIN MICROSPHERES INJECTED INTO THE EXTERNAL JUGULAR ARTERY

Feng Fu

Open publisher page 0 citations

Abstract

Objective To evaluate the distribution and the Artery Vein Access overflow amount of Φ56 3μm albumin microspheres (AMS) injected into the external jugular artery. Methats 125 I labeled AMS was injected into the rabbit's external jugular artery. The proportion of microspheres in the vein blood was measured. The distribution in internal organs of AMS injected through external jugular vein was also observed. Results Only 0 51% of radioactive amount appeared in the vein blood after AMS was injected through external jugular artery. When the AMS was injected through external jugular vein, the embolization of microspheres was found restricted in lung. There was no obvious influence on other important organs. Conclusion Considering of the gentle general side effect, the Φ56 3μm AMS is safe as a drug carrier in infusion chemotherapy of the oral cancer.

About this research paper

What this paper is about

Objective To evaluate the distribution and the Artery Vein Access overflow amount of Φ56 3μm albumin microspheres (AMS) injected into the external jugular artery. Methats 125 I labeled AMS was injected into the rabbit's external jugular artery. The proportion of microspheres in the vein blood was measured. The distribution in internal organs of AMS injected through external jugular vein was also observed. Results Only 0 51% of radioactive amount appeared in the vein blood after AMS was injected through external jugular artery. When the AMS was injected through external jugular vein, the embolization of microspheres was found restricted in lung. There was no obvious influence on other important organs. Conclusion Considering of the gentle general side effect, the Φ56 3μm AMS is safe as a drug carrier in infusion chemotherapy of the oral cancer.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the distribution and the Artery Vein Access overflow amount of Φ56 3μm albumin microspheres (AMS) injected into the external jugular artery. Methats 125 I labeled AMS was injected into the rabbit's external jugular artery. The proportion of microspheres in the vein blood was measured. The distribution in internal organs of AMS injected through external jugular vein was also observed. Results Only 0 51% of radioactive amount appeared in the vein blood after AMS was injected through external jugular artery. When the AMS was injected through external jugular vein, the embolization of microspheres was found restricted in lung. There was no obvious influence on other important organs. Conclusion Considering of the gentle general side effect, the Φ56 3μm AMS is safe as a drug carrier in infusion chemotherapy of the oral cancer.

Key concepts: Jugular vein, External jugular vein, Medicine, Vein, Internal jugular vein, Artery, Albumin, Embolization

Related papers

Back to paper searchBrowse research topicsOriginal source
THE DISTRIBUTION AND ARTERY-VEIN-ACCESS OVERFLOW OF ALBUMIN MICROSPHERES INJECTED INTO THE EXTERNAL JUGULAR ARTERY — Research Paper | ScholarLens